Dihydroartemisinin inhibits EphA2/PI3K/Akt pathway-mediated malignant behaviors and vasculogenic mimicry in glioma stem cells
Gliomas, the most prevalent primary brain tumors, exhibit a poor five-year survival rate despite advances in various treatments, necessitating further studies to understand tumor progression and develop new therapies, particularly targeting EphA2, which is implicated in vasculogenic mimicry and glio...
Saved in:
Main Authors: | Huangde Fu, Shengtian Wu, Hechun Shen, Kai Luo, Zhongxiang Huang, Nankun Lu, Yaolin Li, Qian Lan, Yishun Xian |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-02-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S240584402500475X |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Plasma EphA2 level is a superior biomarker to Del-1 for sepsis diagnosis and prognosis
by: Eun Hye Lee, et al.
Published: (2025-01-01) -
Enhancement of anti‐sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2‐targeted CAR
by: Pui Yeng Lam, et al.
Published: (2025-01-01) -
Machine learning identification of a novel vasculogenic mimicry-related signature and FOXM1’s role in promoting vasculogenic mimicry in clear cell renal cell carcinoma
by: Chao Xu, et al.
Published: (2025-03-01) -
Effects of dietary dihydroartemisinin on growth performance, meat quality, and antioxidant capacity in broiler chickens
by: Xiaoxiao Pu, et al.
Published: (2025-01-01) -
Therapeutic effect of dihydroartemisinin on Alzheimer’s disease model mice with senile macular degeneration
by: Gao Han, et al.
Published: (2025-02-01)